Phase II Study Results
18 May 2011 | By AstraZeneca
AstraZeneca announced encouraging results from a phase II study in patients with platinum-sensitive relapsed serous ovarian cancer...
List view / Grid view
18 May 2011 | By AstraZeneca
AstraZeneca announced encouraging results from a phase II study in patients with platinum-sensitive relapsed serous ovarian cancer...
18 May 2011 | By ThromboGenics NV / BioInvent International AB
Two new studies now ongoing...
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the new Thermo Scientific Fiberlite LEX rotor series, combining lower rotor mass for superior ergonomics with outstanding performance and safety.
17 May 2011 | By Merck
Merck announced that it has entered into agreements with Roche...
17 May 2011 | By Merck
Transaction will strengthen Merck's development and commercialisationof pharmaceutical ophthalmic products...
17 May 2011 | By Novozymes Biopharma
New recombinant hyaluronic acid for eye care and ophthalmic drug delivery...
17 May 2011 | By Glenmark Pharmaceuticals
Sanofi to develop molecule for Crohn’s Disease & other anti-inflammatory conditions...
17 May 2011 | By Amylin Pharmaceuticals
Complaint alleges anti-competitive activity and breach of strategic alliance agreements...
17 May 2011 | By GDS International
For most pharmaceuticals executives, the prospect of the patent cliff is looming large in their thoughts...
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that Eastman Chemical Company, a large global manufacturer of chemicals, fibers and plastics, has expanded its deployment of Thermo Scientific SampleManager LIMS (laboratory information management system), which it has used since 2000 in its manufacturing quality control laboratories,…
13 May 2011 | By European Pharmaceutical Review
Pfizer will settle more than 2,200 lawsuits alleging the company's Wyeth unit hid Prempro's cancer risks...
13 May 2011 | By pSivida Corp.
A New Drug Application for the investigational drug ILUVIEN® for the treatment of diabetic macular edema (DME) has been resubmitted...
13 May 2011 | By Merck
VICTRELIS is approved for the treatment of CHC genotype 1 infection...
11 May 2011 | By Fleming Europe
Network with c-level industry leaders from AstraZeneca, Sanofi Aventis, Roche, Novartis, Baxter, Pfizer & Abbott...
10 May 2011 | By Sanofi Pasteur
The FDA approved Sanofi Pasteur’s sBLA for licensure of Fluzone Intradermal...